| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |